Company Filing History:
16 out of 46 
1 out of 832,761 Years Active: 2009-2018
Title: Innovations of Eti Kovalevski-Ishai
Introduction
Eti Kovalevski-Ishai is a prominent inventor based in Netania, Israel. He has made significant contributions to the field of phospholipid synthesis, holding a total of 17 patents. His work focuses on developing novel synthetic routes that are highly applicable for industrial preparation of therapeutically beneficial oxidized phospholipids.
Latest Patents
Among his latest patents, Eti has disclosed methods for efficiently preparing compounds with a glycerolic backbone and one or more oxidized moieties attached to it. These methods are devoid of column chromatography, which enhances their industrial applicability. Additionally, he has introduced novel methods for incorporating phosphorus-containing moieties, such as phosphate moieties, into these compounds. One of his notable inventions is the substantially pure 1-hexadecyl-2-(4'-carboxy)butyl-sn-glycero-3-phosphocholine (CI-201).
Career Highlights
Eti has worked with Vascular Biogenics Ltd., where he has further honed his expertise in the field. His innovative approaches have positioned him as a key figure in the development of phospholipid-based therapies.
Collaborations
Throughout his career, Eti has collaborated with notable professionals, including Gideon Halperin and Niva Yacov, who is a distinguished woman in the field.
Conclusion
Eti Kovalevski-Ishai's contributions to the field of phospholipid synthesis are noteworthy, and his innovative patents continue to influence therapeutic applications. His work exemplifies the importance of innovation in advancing medical science.